What are the relevant ICD-10 (International Classification of Diseases, 10th Revision) codes for a patient presenting with an adrenal nodule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Codes for Adrenal Nodule

The primary ICD-10 code for an adrenal nodule is D35.0 (Benign neoplasm of adrenal gland), which is appropriate for most incidentally discovered adrenal masses pending further characterization.

Primary Coding Options

The specific ICD-10 code selection depends on the clinical context and degree of characterization:

Benign Lesions

  • D35.0 - Benign neoplasm of adrenal gland (most commonly used for adrenal incidentalomas and adenomas) 1
  • D44.1 - Neoplasm of uncertain behavior of adrenal gland (for indeterminate masses requiring further workup) 1

Specific Benign Subtypes

  • D35.0 also applies to:
    • Nonfunctioning adenomas (71-84% of incidentalomas) 1
    • Myelolipomas (7-15% of incidentalomas) 1, 2
    • Ganglioneuromas (0-8% of incidentalomas) 1

Functional Adenomas

  • E24.0 - Pituitary-dependent Cushing's disease
  • E24.8 - Other Cushing's syndrome (for cortisol-secreting adenomas, 1-30% of incidentalomas) 1
  • E26.0 - Primary hyperaldosteronism (for aldosterone-secreting adenomas, 2-7% of incidentalomas) 1
  • D35.0 with E27.5 - Adrenomedullary hyperfunction (for pheochromocytomas, 1.5-14% of incidentalomas) 1

Malignant Lesions

  • C74.0 - Malignant neoplasm of cortex of adrenal gland (for adrenocortical carcinoma, 1.2-12% of incidentalomas) 1
  • C79.7 - Secondary malignant neoplasm of adrenal gland (for metastases, 0-21% of incidentalomas, though higher in patients with known extra-adrenal malignancy at 25-72%) 1, 3, 4

Other Adrenal Pathology

  • E27.8 - Other specified disorders of adrenal gland (for adrenal cysts, 4-22% of incidentalomas) 1
  • E27.49 - Other adrenocortical insufficiency (if bilateral involvement causes adrenal insufficiency) 4

Coding Strategy Based on Clinical Scenario

For initial presentation of an incidental finding: Use D35.0 or D44.1 depending on imaging characteristics (D35.0 if <10 HU on unenhanced CT confirming benign lipid-rich adenoma; D44.1 if >10 HU requiring further characterization) 1, 3, 5

After hormonal workup: Add appropriate functional codes (E24.8, E26.0, E27.5) if autonomous hormone secretion is confirmed 1, 3

After definitive characterization: Use specific codes based on final diagnosis (C74.0 for adrenocortical carcinoma if tumor >4 cm with irregular margins or heterogeneous appearance; D35.0 for confirmed benign adenoma) 1

Critical Coding Pitfalls to Avoid

  • Do not use malignancy codes (C74.0, C79.7) without pathologic confirmation or strong radiologic evidence, as most small adrenal nodules (<4 cm) are benign with malignancy prevalence of only 0.3% in nodules <4 cm and 0.06% risk for primary adrenocortical carcinoma in the general population 3, 6, 7

  • Avoid using "uncertain behavior" code (D44.1) for masses definitively characterized as benign (HU ≤10 on unenhanced CT), as these are definitively benign lipid-rich adenomas requiring no further workup 1, 3, 5

  • Include functional codes when appropriate, as approximately 5% of radiologically benign incidentalomas have subclinical hormone production requiring treatment 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Adrenal Myelolipoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Small Adrenal Masses

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Incidental Adrenal Mass

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.